BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34128351)

  • 21. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.
    Ling LJ; Lu Y; Zhang YY; Zhu HY; Tu P; Li H; Chen DF
    Phytomedicine; 2020 Feb; 67():153150. PubMed ID: 31958713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses.
    Chang SY; Huang KY; Chao TL; Kao HC; Pang YH; Lu L; Chiu CL; Huang HC; Cheng TR; Fang JM; Yang PC
    Sci Rep; 2021 Apr; 11(1):8692. PubMed ID: 33888738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action.
    De Angelis M; Casciaro B; Genovese A; Brancaccio D; Marcocci ME; Novellino E; Carotenuto A; Palamara AT; Mangoni ML; Nencioni L
    FASEB J; 2021 Feb; 35(2):e21358. PubMed ID: 33538061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein.
    Littler DR; Liu M; McAuley JL; Lowery SA; Illing PT; Gully BS; Purcell AW; Chandrashekaran IR; Perlman S; Purcell DFJ; Quinn RJ; Rossjohn J
    J Biol Chem; 2021 Dec; 297(6):101362. PubMed ID: 34756886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydromaniwamycin E, a Heat-Shock Metabolite from Thermotolerant
    Saito S; Funayama K; Kato W; Okuda M; Kawamoto M; Matsubara T; Sato T; Sato A; Otsuguro S; Sasaki M; Orba Y; Sawa H; Maenaka K; Shindo K; Imoto M; Arai MA
    J Nat Prod; 2022 Nov; 85(11):2583-2591. PubMed ID: 36223390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
    Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
    J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral Activity of the Propylamylatin
    Brown AN; Strobel G; Hanrahan KC; Sears J
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
    Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
    Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).
    Yuan S; Chan CC; Chik KK; Tsang JO; Liang R; Cao J; Tang K; Cai JP; Ye ZW; Yin F; To KK; Chu H; Jin DY; Hung IF; Yuen KY; Chan JF
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32532085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.
    Park BK; Kim J; Park S; Kim D; Kim M; Baek K; Bae JY; Park MS; Kim WK; Lee Y; Kwon HJ
    Theranostics; 2021; 11(8):3853-3867. PubMed ID: 33664866
    [No Abstract]   [Full Text] [Related]  

  • 31. Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication.
    Pirzada RH; Haseeb M; Batool M; Kim M; Choi S
    Cells; 2021 Apr; 10(5):. PubMed ID: 33946869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity.
    Nittayananta W; Lerdsamran H; Chutiwitoonchai N; Promsong A; Srichana T; Netsomboon K; Prasertsopon J; Kerdto J
    Virol J; 2024 Jan; 21(1):26. PubMed ID: 38263162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.
    Hsieh CF; Lo CW; Liu CH; Lin S; Yen HR; Lin TY; Horng JT
    J Ethnopharmacol; 2012 Aug; 143(1):57-67. PubMed ID: 22710290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.
    Savastano A; Ibáñez de Opakua A; Rankovic M; Zweckstetter M
    Nat Commun; 2020 Nov; 11(1):6041. PubMed ID: 33247108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
    Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
    Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
    Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential nucleocytoplasmic shuttling of the nucleoprotein of influenza a viruses and association with host tropism.
    Li J; Zheng W; Hou L; Chen C; Fan W; Qu H; Jiang J; Liu J; Gao GF; Zhou J; Sun L; Liu W
    Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27862840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gallium maltolate has
    Bernstein LR; Zhang L
    Antivir Chem Chemother; 2020; 28():2040206620983780. PubMed ID: 33353394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate inhibits SARS-CoV-2 virus replication "in vitro".
    Caruso A; Caccuri F; Bugatti A; Zani A; Vanoni M; Bonfanti P; Cazzaniga ME; Perno CF; Messa C; Alberghina L
    J Med Virol; 2021 Mar; 93(3):1780-1785. PubMed ID: 32926453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.